Cathepsins D, B, and L in transformed human breast epithelial cells

Breast Cancer Research and Treatment

Volumn 39, Issue 2, 1996, Pages 221-233

  Lah, Tamara T ^a,c   Calaf, Gloria ^b   Kalman, Endre ^a   Shinde, Balasahib G ^a   Somers, Robert ^a   Estrada, Sandino ^b   Salero, Enrique ^b   Russo, Jose ^b   Daskal, Ierachmiel ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c Department of Pathology   (United States)

Author keywords

Breast cancer; c Ha ras oncogene; Carcinogens; Cathepsin B; Cathepsin D; Cathepsin L; Invasion; Tumorigenicity

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; LYSOSOME ENZYME;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER INVASION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; ONCOGENE C H RAS; PRIORITY JOURNAL; SCID MOUSE;

EID: 0029788434     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806189     Document Type: Article

References (41)

1. Sloane BF, Moin K, Lah TT: Lysosomal enzymes and their endogenous inhibitors in neoplasia. In: Pretlow TG, Pretlow TH (eds) Biochemical and Molecular Aspects of Selected Cancers. Acad. Press, New York, 1993 vol 2: pp 411-466
2. Lah TT, Kokalj-Kunovar M, Štrukelj B, Pungerčar J. Maganja D-B, Drobnič-Koškorok M. Kastelic L, Babnik J. Golouh R, Turk V: Stefins and lysosomal cathepsins B. L and D in human breast carcinoma. Int J Cancer 50: 36-44, 1992
3. Gabrijelčič D, Svetic B, Spaič D, Šrk J, Budihna M, Dolenec I. Popovič T. Cotič V. Turk V: Cathepsins B, H and L in human breast. Europ J Clin Chem Clin Biochem 30: 69-74, 1992
4. Rochefort H, Capony F, Garcia M: Cathepsin D: A protease involved in breast cancer metastasis. Cancer and Metastasis Reviews 9: 321-331, 1990
5. Ravdin PM: Evaluation of cathepsin D as a prognostic lactor in breast cancer. Breast Cancer Research and Treatment 24: 219-226, 1993
6. Garcia M, Deroq D, Pujol P, Rochefort H: Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 5: 1809-1814, 1990
7. Capony F, Rougeot C, Cavailles V, Rochefort H: Estradiol increases the secretion by MCF7 cells of several lysosomal pro-enzymes. Biochem Biophys Res Commun 171: 972-987, 1990
8. Mort JS, Recklies AD: Interrelationship of active and latent secreted human cathepsin B precursors. Biochem J 233: 57-63, 1986
9. Krepela E, Bartek J, Skalkova D, Vicar J, Rasnick D, Taylor-Papadimitriou J, Hallowes RC: Cytochemical and biochemical evidence of cathepsin B in malignant, transformed and normal breast epithelial cells. J Cell Science 87: 145-154, 1987
10. Chuahan SS, Goldstein LJ, Gottesman MM: Expression of cathepsin L in human tumors. Cancer Res 50: 1478-1480, 1990
11. Kane SS, Gottesman MM: The role of cathepsin L in malignant transformation. Seminars in Cancer Biology 1: 127-136, 1990
12. Chambers AF, Collela R, Denhardt DT, Wilson SM: Increased expression of cathepsins L and B, and decreased activity of their inhibitors, in metastatic, ras-transformed NIH 3T3 cells. Mol Carcinogenesis 5: 238-245, 1992
13. Chambers AF, Tuck AB: Ras-responsive genes and tumor metastasis. Critical Reviews in Oncogenesis 4: 95-114, 1993
14. Zhang J-Y, Schultz RM: Fibroblasts transformed by different ras oncogenes show dissimilar patterns of protease gene expression and regulation. Cancer Res 52: 6682-6689, 1992
15. Sloane BF, Rozhin J, Moin K, Ziegler G, Fong D, Muschel RJ: Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts. Biol Chem Hoppe-Seyler 373: 589-594, 1992
16. Calaf G, Russo J:Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14: 483-492, 1993
17. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, MacGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6078-6094, 1990
18. Basolo F, Elliott J, Tait L, Chen XQ, Maloney T, Russo IH, Pauley R, Momiki S, Caamano J, Klein-Szanto AJP, Koszalka M, Russo J: Transformation in human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinogenesis 4: 25-35, 1991
19. Calaf G, Tahin Q, Alvarado ME, Estrada S, Cox T, Russo J: Hormone receptors and cathepsin D levels in human breast epithelial cells transformed by chemical carcinogens and c-Ha-ras transfection. Breast Cancer Res and Treatment 29: 169-177, 1993
20. Calaf G, Estrada S, Zhang P-L, Alvarado ME, Russo J: c-Ha-ras oncogene enhances the tumorigenic phenotype of human breast epithelial cells transformed with a chemical carcinogen in vitro. Proc Am Assoc Cancer Res 34: 120, 1993
21. Bradford M: A rapid, sensitive method for the quantitation of μg quantities of protein, utilizing the principle of proteindye binding. Anal Biochem 72: 248-254, 1976
22. Briozzo P, Morisset M, Capony F, Rougeot C, Rochefort H: In vitro degradation of extracellular matrix. Cancer Res 48: 3688-3692, 1988
23. Mason RW, Green GDJ, Barrett AJ: Human liver cathepsin L. Biochem J 226: 233-241, 1986
24. Russo J, Russo IH, Calaf G, Zhang P-L, Barnabas N: Breast susceptibility to Carcinogenesis. In: Nandi S. Li J. (eds). Hormonal Carcinogenesis, Springer Verlag Berlin, 1995 (in press)
25. 980I. Proc Am Assoc Cancer Res 35: 164, 1994
26. Lah TT, Calaf G, Kalman E, Russo J, Jarosz D, Zabrecky J, Somers R and Daskal I: Cathepsins D, B, and L in breast carcinoma and in transformed human breast epithelial cell (HBEC). Biol Chem Hoppe Seyler 376: 357-376, 1995
27. Johnson MD, Torri JA, Lippman ME, Dickson RB: The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res 53: 7873-7877, 1993
28. Gabel CA, Goldberg DE, Kornfeld S: Identification and characterization of cells deficient of the mannose-6-phosphate receptor: evidence for an alternative pathway for lysosomal enzyme targeting. Proc Natl Acad Sci USA 80: 775-781, 1983
29. Brouillet JP, Spyratos F, Hacene K, Fauque J, Freiss G, Dupont F, Maudelonde T, Rochefort H: Immunoradiometric assay of pro-cathepsin D in breast cancer cytosols relative prognostic value versus total cathepsin D. Europ J Cancer 29A: 9: 1248-1251, 1993
30. Zhang P-L, Calaf G, Russo H: Allele loss and point mutation in codons 12 and 61 of the c-Ha-ras oncogene in carcinogen-transformed human breast epithelial cells. Molecular Carcinogenesis 9: 46-56, 1994
31. Sloane BF, Moin K, Sameni M, Tait LR, Rozhin J, Ziegler G: Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J Cell Science 107: 373-384, 1994
32. Sloane BF, Sameni M, Cao L, Berquin I, Rozhin J, Ziegler G, Moin K, Day N: Alterations in processing and trafficking of cathepsin B during malignant progression. In: Katunuma N, Suzuki K, Travis J, Fritz H (eds) Biological Functions of Proteases and Inhibitors. Japan Sci Soc Press Tokyo, 1993 pp 131-147, 1993
33. Lah TT, Kokalj-Kunovar M, Drobnič-Košorok M, Babnik J, Golouh R, Vrhovec I, Turk V: Stefins and cathepsins in breast carcinoma. Biol Chem Hoppe-Seyler, Suppl 371:434-438, 1992
34. Kolar Z, Järvinen M, Negrini R: Demonstration of proteinase inhibitors cystatin A, B and C in breast cancer and in cell lines MCF-7 and ZR-75-1. Neoplasma. 36: 185-189, 1989
35. Hamilton RT, Bruns KA, Delgado ME, Shim JK, Fang Y, Denhardt DT, Hamilton MN: Developmental expression of cathepsin L and c-Ha-ras in the mouse placenta. Mol Reproduction and Development 30: 285-291, 1991
36. Mason RW, Wilcox D, Wikstrom P, Shaw E: The identification of active forms of cysteine proteinases in Kirsten-virus transformed mouse fibroblasts by use of a specific radiolabelled inhibitor. Biochem J 248: 449-454, 1989
37. Gal S, Gottesman MM: The major excreted protein of transformed fibroblasts is an acid activatable protease. J Biol Chem 262: 1760-1765, 1986
38. Lee HK, Jones RT, Myers R, Marzella L: Regulation of protein degradation in normal and transformed human bronchial epithelial cells in culture. Arch Biochem Biophys 296: 271-278, 1992
39. Gunn JM, James G: Protein turnover in 3T3 cells transformed with the oncogene c-H-rasl. Biochem J 283: 427-433, 1992
40. Russo J, Russo IH: Biology of disease: Biological and molecular bases of mammary carcinogenesis. Laboratory Invest 57: 112-137, 1987
41. Lah TT, Vrhovec I, Golouh R, Babnik J, Turk V, Tabachnick I, Daskal I: Lysosomal proteinases in malignant breast carcinoma. Clinical and Exp Metastasis 10: Suppl 1, p 72, 1992